Eli Lilly Acquires Houston Biotech Startup
Months after investing in Houston, Eli Lilly is acquiring local biotech startup CrossBridge Bio.
As one of the fastest growing life sciences ecosystems, Houston’s world-class medical centers, research institutions and private companies are positioned to take on the greatest medical challenges of our generation.

We're excited to have you exploring more of Houston's dynamic life sciences ecosystem. Be sure to see our region by the numbers, see the most recent updates from Greater Houston, or engage with us to see where we can work together.

Learn More
With $1 billion in annual research investment, Houston offers leading companies access to the youngest, fastest growing and most diverse workforces in the country, powered by strategic upskilling and academic collaborations.
(2020 - 2025)
Months after investing in Houston, Eli Lilly is acquiring local biotech startup CrossBridge Bio.
Houston’s biotech industry continues to drive interest and investment.
Houston is rapidly emerging as a leader in medical technology, building on decades of innovation.
News | September 23, 2025
Houston Wins Texas' First Major Pharma Plant With $6.5B Investment
Eli Lilly is investing $6.5 billion into Houston's Generation Park to build a 236-acre manufacturing facility.
